Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS + Exposure Therapy for Pediatric OCD

NCT: NCT05931913 · ACTIVE_NOT_RECRUITING

NCT IDNCT05931913
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-20
Completion2026-07-31

Brief Summary

The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will: * Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)

Frequently Asked Questions

What is TMS + Exposure Therapy for Pediatric OCD?

TMS + Exposure Therapy for Pediatric OCD is a clinical trial registered under NCT05931913. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05931913?

The current status of NCT05931913 (TMS + Exposure Therapy for Pediatric OCD) is: ACTIVE_NOT_RECRUITING.

When did TMS + Exposure Therapy for Pediatric OCD start?

TMS + Exposure Therapy for Pediatric OCD started on 2024-03-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.